Literature DB >> 17907288

An optimized 13C-urea breath test for the diagnosis of H pylori infection.

Germán Campuzano-Maya1.   

Abstract

AIM: To validate an optimized (13)C-urea breath test ((13)C-UBT) protocol for the diagnosis of H pylori infection that is cost-efficient and maintains excellent diagnostic accuracy.
METHODS: 70 healthy volunteers were tested with two simplified (13)C-UBT protocols, with test meal (Protocol 2) and without test meal (Protocol 1). Breath samples were collected at 10, 20 and 30 min after ingestion of 50 mg (13)C-urea dissolved in 10 mL of water, taken as a single swallow, followed by 200 mL of water (pH 6.0) and a circular motion around the waistline to homogenize the urea solution. Performance of both protocols was analyzed at various cut-off values. Results were validated against the European protocol.
RESULTS: According to the reference protocol, 65.7% individuals were positive for H pylori infection and 34.3% were negative. There were no significant differences in the ability of both protocols to correctly identify positive and negative H pylori individuals. However, only Protocol 1 with no test meal achieved accuracy, sensitivity, specificity, positive and negative predictive values of 100%. The highest values achieved by Protocol 2 were 98.57%, 97.83%, 100%, 100% and 100%, respectively.
CONCLUSION: A 10 min, 50 mg (13)C-UBT with no test meal using a cut-off value of 2-2.5 is a highly accurate test for the diagnosis of H pylori infection at a reduced cost.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907288      PMCID: PMC4171279          DOI: 10.3748/wjg.v13.i41.5454

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  110 in total

Review 1.  Overview: Helicobacter pylori and extragastric disease.

Authors:  Hidekazu Suzuki; Barry James Marshall; Toshifumi Hibi
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  13C-urea breath test for the diagnosis of Helicobacter pylori infection. A further simplification for clinical practice.

Authors:  A Leodolter; J E Domínguez-Muñoz; U von Arnim; G Manes; P Malfertheiner
Journal:  Scand J Gastroenterol       Date:  1998-03       Impact factor: 2.423

4.  Accuracy of 13C-urea breath test in clinical use for diagnosis of Helicobacter pylori infection.

Authors:  R L Riepl; C Folwaczny; B Otto; A Klauser; C Blendinger; B Wiebecke; A König; P Lehnert; W Heldwein
Journal:  Z Gastroenterol       Date:  2000-01       Impact factor: 2.000

5.  Application of isotope-selective non-dispersive infrared spectrometry for the evaluation of the 13C-urea breath test: comparison with three concordant methods.

Authors:  L G Coelho; M Reber; M C Passos; R O Aguiar; P E Casaes; M L Bueno; F R Yazaki; F J Castro; W L Vieira; J M Franco; L P Castro
Journal:  Braz J Med Biol Res       Date:  1999-12       Impact factor: 2.590

6.  Twenty-minute fasting version of the US 13C-urea breath test for the diagnosis of H. pylori infection.

Authors:  H M Malaty; H M el-Zimaity; R M Genta; P D Klein; D Y Graham
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

7.  Trials of novel 13C-urea-containing capsule for more economic and sensitive diagnosis of Helicobacter pylori infection in human subjects.

Authors:  Chul Soon Yong; Yong-Il Kim; San-Man Park; Rham Kwon; Hong-Hee Han; Jung Gil Park; Chan-Yoo Yang; Jung-Ae Kim; Bong-Kyu Yoo; Jong-Dal Rhee; Han-Gon Choi
Journal:  Arch Pharm Res       Date:  2006-10       Impact factor: 4.946

8.  Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America.

Authors:  Germán Campuzano-Maya
Journal:  Helicobacter       Date:  2007-06       Impact factor: 5.753

Review 9.  Clinical studies of 13C-urea breath test in Japan.

Authors:  M Kato; M Asaka; S Ohara; T Toyota
Journal:  J Gastroenterol       Date:  1998       Impact factor: 7.527

10.  Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.

Authors:  Luigi Gatta; Nimish Vakil; Chiara Ricci; John F Osborn; Andrea Tampieri; Federico Perna; Mario Miglioli; Dino Vaira
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

View more
  6 in total

1.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

Review 2.  Update on diagnostic value of breath test in gastrointestinal and liver diseases.

Authors:  Imran Siddiqui; Sibtain Ahmed; Shahab Abid
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

3.  Effect of posture on (13)C-urea breath test in partial gastrectomy patients.

Authors:  Shu-Ming Yin; Fan Zhang; Dong-Mei Shi; Ping Xiang; Li Xiao; Yi-Qin Huang; Gan-Sheng Zhang; Zhi-Jun Bao
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

4.  Effect of gastric acidification on the (14)C-UBT HELIPROBE(®) accuracy during Pantoprazole treatment in Helicobacter pylori positive patients.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Mohammad Reza Sheykhian; Fatemeh Soati; Ali Mohammad Rafatzand
Journal:  Int J Clin Exp Med       Date:  2013-03-21

5.  Helicobacter pylori infection is not associated with failure to thrive: a case control study.

Authors:  Nan-Chang Chiu; Chien-Yu Lin; Hsin Chi; Chun-Yan Yeung; Wei-Hsin Ting; Wai-Tao Chan; Chuen-Bin Jiang; Sung-Tse Li; Chao-Hsu Lin; Hung-Chang Lee
Journal:  Ther Clin Risk Manag       Date:  2017-02-23       Impact factor: 2.423

Review 6.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.